BEUDAMED
    FDA PMA 30-Day Notice Accepted 🇺🇸 United States

    PMA: P010031 · Supplement: S384 · Decision Jul 26, 2013
    View on FDA
    Classifications
    0
    FEI Numbers
    0
    Registration Numbers
    0

    Basic Information

    Trade Name
    CONCERTO II CRT-D, CONSULTA ICD, MAXIMO CRT-D
    PMA Number
    P010031
    Supplement Number
    S384
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    July 26, 2013
    Date Received
    June 26, 2013
    Supplement Type
    30-Day Notice
    Expedited Review
    N

    Advisory Committee Statement

    UPDATE TO THE NEXT GENERATION HYBRID TESTER TO RELEASE 35.0.